formoline-L112-logo

Κλινικές Μελέτες

Intestinal fat absorption by a polyglucosamine biopolymer controls lipids and reduces the progression of early, subclinical atherosclerosis.

Formoline shows positive effects of on the lipid profile, weight, fat mass and oxidative stress due to the combination of IFAS and a mild diet. These activities showed a significant protection of arterial wall structures measured with the ultrasound scanning in a two years period of management and in subjects with subclinical conditions.

A Randomized Double-Blind Placebo-Controlled Clinical Study to Evaluate the Effect on the Weight of a Medical Device with Polyglucosamine L112 in a Group of Overweight and Obese Subjects.

Formoline acts as a safe medical device, is not absorbed, and binds lipids in the upper gastrointestinal tract, reducing their availability, with a significant activity on the reduction of BW, insulin resistance, and cholesterol levels without the modification of fat-soluble vitamins.

Long-Term Treatment of Overweight and Obesity with Polyglucosamine (PG L112)_ Randomized Study Compared with Placebo in Subjects after Caloric Restriction photo

Long-Term Treatment of Overweight and Obesity with Polyglucosamine (PG L112): Randomized Study Compared with Placebo in Subjects after Caloric Restriction

Short-term treatment of overweight and obesity with polyglucosamine (PG) was found to be more effective than placebo and orlistat in double-blind clinical studies.

Information for professionals photo

Information for professionals

Guideline-based use and efficacy of the lipid binders formoline L112 and formoline L112 EXTRA in the therapy of overweight and obesity

Randomised, double-blind, clinical investigation to compare orlistat 60 milligram and a customized polyglucosamine, two treatment methods for the management of overweight and obesity

Randomised, double-blind, clinical investigation to compare orlistat 60 milligram and a customized polyglucosamine, two treatment methods for the management of overweight and obesity

The efficacy of a non-prescription drug to support weight loss programs has yet to be compared. This clinical trial investigates the comparability of orlistat 60 milligram (mg) and polyglucosamine.

A single oral dose of a polyglucosamine influences the bioavailability of [9-(14)C]-Oleic acid in adult female Göttingen minipigs photo

A single oral dose of a polyglucosamine influences the bioavailability of [9-14C]- Oleic acid in adult female Göttingen minipigs

The objective of this study is to investigate the influence of polyglucosamine on the bioavailability of the model compound [9-14C]-oleic acid in female Göttingen minipigs.

Efficacy of polyglucosamine for weight loss-confirmed in a randomized double-blind, placebo-controlled clinical investigation photo

Efficacy of polyglucosamine for weight loss—confirmed in a randomized double-blind, placebo-controlled clinical investigation

The purpose of this clinical study was to ascertain whether low molecular weight chitosan polyglucosamine is able to produce significantly better weight loss than placebo.

Οδηγίες Χρήσης formoline L112 EXTRA photo

Οδηγίες χρήσης

Διαβάστε προσεκτικά αυτές τις οδηγίες χρήσης πριν τη λήψη του formoline L112 EXTRA.